David Hoffmeister, Eric Winzer, Ludwig Huber, William Knight, Grant Thornton, Laura Francis, Kevin Farr, Charles Haggerty, Udo Klein, Steven Knapp, Kate Gilbert, Dick Rubin | GenomeWeb

Invitrogen on Tuesday named David Hoffmeister as chief financial officer, replacing Eric Winzer, who held the post since 2002. Winzer will remain on the Invitrogen staff and will manage the installation of enterprise resource planning for the company, typically a lengthy and expensive information technology project. Hoffmeister comes to Invitrogen after 20 years at McKinsey & Co., where he left as a senior partner specializing in mergers and acquisitions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.